Sarah Hersey

Title: The Innovative Contributions of Sarah Hersey

Introduction

Sarah Hersey is a notable inventor based in Mendham, NJ (US). She has made significant contributions to the field of medical research, particularly in the classification of diffuse large B-cell lymphoma. Her work has the potential to improve diagnostic accuracy and patient outcomes.

Latest Patents

Hersey holds a patent for a method of predicting if a subject has an Activated B Cell-like (ABC) subtype or a non-ABC subtype of Diffuse Large B-Cell Lymphoma (DLBCL). The patent outlines a comprehensive approach that includes obtaining a sample from the subject, measuring the expression levels of CD10, MUM1, FOXP1, and optionally Bcl-6. It also involves determining a composite score based on these expression levels and predicting the subtype of DLBCL based on the score. This innovative method is crucial for enhancing the understanding and treatment of this type of lymphoma. She has 1 patent to her name.

Career Highlights

Sarah Hersey is currently employed at Celgene Corporation, where she continues to advance her research in oncology. Her work at Celgene has allowed her to collaborate with leading experts in the field and contribute to groundbreaking studies.

Collaborations

One of her notable collaborators is Fadi George Towfic. Together, they have worked on various projects aimed at improving cancer diagnostics and treatment strategies.

Conclusion

Sarah Hersey's innovative work in the classification of diffuse large B-cell lymphoma exemplifies the impact of research on patient care. Her contributions are paving the way for advancements in oncology and improving the lives of many patients.